维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

15篇 您的检索式：作者名="Robinet F"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Peripheral T-cell expan- sion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cd\| transplantation 显示文摘	Larosa F Mmnier C Robinet E	2005	Blood Marrow Transplant2005，35，9：	1
	2	Activation of the beta-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304carcinoma cells显示文摘	Manpas-Schwalm F Robinet C Augé N	2005	Cancer Res2005，65，：	1
	3	Second line therapy with gefitinib in combination with doeetaxel for advanced non-small cell lung cancer: a phase Ⅱ randomized study显示文摘	Robinet G Barlesi F Fournel P	2007	Targ Oncoh2007，2，2：	1
	4	An open muhicenter phase Ⅱ trial of weekly docetaxel for advanced-stage non-smallcell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study 显示文摘	LeCaer H Barlesi F Robinet G	2007	Lung Cancer2007，57，1：	1
	5	An open multicenter phase Ⅱ trial of weekly docetaxel for advanced stage non-small cell lung cancer in elderly patients with significant comorbidity and/or poor performance status:the GFPC 02202b study显示文摘	TLECAER H BARLESI F ROBINET G	2007	Lung Cancer2007，57，1：	1
	6	Synergy of entry inhibitors with direct-Acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C显示文摘	Xiao F Fofana I Thumann C Mailly L Alles R Robinet E Meyer N Schaeffer M Habersetzer F Doffol M Leyssen P Neyts J Zeisel M B Baumert T F	2014	Gut2014，，：	1
	7	Pe- ripheral T-cell expansion and low infection rate after re- duced-intensity conditioning and allogeneic blood stem cell transplantation 显示文摘	LAROSA F MARMIER C ROBINET E	2005	Bone Marrow Transplantation2005，35，9：	1
	8	A constitutive thermomechanical model for saturated clays显示文摘	ROBINET J C RAHBAOUI A PLAS F	1996	Engineering Geology1996，41，1：	1
	9	An open multicenter phase Ⅱ trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant eomorbidity and/or poor performance status: The GFPC 02- 02b study 显示文摘	LeCaer H Barlesi F Robinet G	2007	Lung Cancer2007，57，1：	1
	10	An open multicenterphase II trial of weekly docetaxel for advanced - stage non -small - cell lung cancer in elderly patients with significant comor-bidity and/or poor performance status:The GFPC 02 -02b study显示文摘	LeCaer H Barlesi F Robinet G	2007	Lung Cancer2007，57，1：	1
	11	MTF measurement using spotlight显示文摘	Leger D Duffaut J Robinet F	1994	IEEE Transactions on Geoscience and Remote Sensing1994，4，：	1
	12	An open multicenter phase II trial of weekly doeetaxel for advanced-stage non-small-cell lung cancer in elderly patients with signficant comorbidity and /or poor performance status: The GFPC 02-02b study显示文摘	LeCaer H Barlesi F Robinet G	2007	Lung Cancer2007，57，1：	1
	13	Activation of the { beta} - catenin/T - cell - specific transcription factor/ lymphoid enhancer factor - 1 pathway by plasminogen activators in ECV304 carcinoma cells 显示文摘	Maupas - Schwalm F Robinet C Auge N	2005	Cancer Res2005，65，2：	1
	14	The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation,cell proliferation,and uPAR overexpression induced by tissue-type plasminogen activator显示文摘	Maupas-Schwalm F Augé Robinet C		0，，12：	1
	15	Binding of elastin peptides to S-Gal protects the heart against ischemial reperfusion injury by triggering the RISK pathway 显示文摘	Robinet A Millart H Oszust F	2007	FASEB J2007，21，9：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费